Developing Innovative Software Solutions and Technology Expertise for Pharma

Developing Innovative Software Solutions and Technology Expertise for Pharma

Headquarter In: Princeton, NJ
Founded in Year: 2010
Employees Headcount: 201-500


Introduction and Background of the company

Techsol Corporation was founded in 2010 under the leadership of Satya S S Sagi, CEO with his vision for offering value-based technology services and developing innovative software solutions for pharma. With over 20 years of life sciences industry experience, the humble beginnings of Techsol was started by him on a small penthouse overseeing Hi-Tec city in Hyderabad, India. Today with our headquarters in Princeton, NJ, we are recognized as a valuable tech partner for several global clients with an expanded team of 140+ subject matter experts.

With over 10+ years of industry experience, we have learnt that keeping up a commitment and winning the trust of clients comes only with diligence, integrity, transparency, and continuous pursuit of excellence. In short these have been our ingredients to develop a sustainable innovation mindset regardless of shortcomings. Above all, we have developed the virtue of being agile to adapt, evolve and align ourselves constantly with our client’s business goals.

We provide business-value to our clients by delivering high-quality configurable solutions & specialized services with the focus on quality and regulatory compliance. Our core domain expertise was developed using our committed domain experts through constant industry interactions, and by adopting industry best practices.  For eg: All validation services we provide are in alignment to the GAMP5 risk-based validation framework. Our Service Desk operations are run by using the principles of ITIL and we deliver projects using the PmBOK methodology.

We currently focus on providing technology and technology enabled data services to address some of the specific challenges of Pharma in the R&D, Medical Affairs and Commercial processes. In the Clinical Development and Pharmacovigilance, we offer system integrations services and Managed cloud services (Accel Solutions) in partnership with Oracle Health Sciences. We also, actively developing PVSentinel platform that address some of the operational challenges of Pharmacovigilance by utilizing AI/ Automation and digital approaches.

In the Medical Affairs domain, we began developing “MedInquirer” about 4 years ago and this was our first cloud solution just for medical communications. Today, we have broadened our innovation landscape by launching SciMax Global (www.scimaxglobal.com) which is a patient-centric Outcomes & Evidence driven global medical affairs platform.

Our commitment to introduce high-end technology through SciMax for Medical Affairs will be a game changer for Pharma & Service providers. We will be the first company to provide such a comprehensive collaborative platform for multi-functional stakeholders. As we look more closely, we know for a fact that this adaptive change requires synergy with other business systems. Hence, we have dedicated ourselves to building configurable technology solutions which can easily support cross-platform integrations.

Joe Pierce, CEO, SciMax Global says, “I’ve been in the industry for nearly 25 years and Techsol’s SciMax is simply the best Medical Affairs solution available. We are extremely excited to continue to enhance, develop, implement, and support for end to end management of Medical Affairs

Business Challenges associated with offering Technology driven services to Pharma

Keeping up to speed with rapid advancements in technology requires considerable amount of dedication to reduce talent development time. Understanding the challenge and offering the right solution for clients with changing tech requirements is a key specialty for us because we have learned to thrive with agility.

With all the market entry barriers, timing is an essential component of innovation success. Its primarily for that reason, we have established synergetic relationships with our clients and partners to derive value from their knowledge and in offer our technology expertise.  Another important success factor that we were able to leverage successfully is our tactical capability to reuse technical and knowledge assets to solve problems more effectively.

With our pharma industry domain expertise & strong technology experience, we have proven capabilities to:

– Build & deliver configurable, process-oriented digital platforms for pharma

– Provide lean and integrated cloud solutions

– Offer actionable intelligence with advanced data analytics

– Transform business processes with incremental innovation

“Our vision is to become a pioneer in providing value-driven, high quality, process-oriented technology services and simplified business solutions for the pharmaceutical industry,” says Satya S S Sagi, founder and CEO of Techsol

Working with Strategic customers

We have been providing unparalleled technical and functional consulting guidance across the clinical development, drug safety and medical affairs verticals with strategic business partnerships. We had the opportunity of implementing and rolling out SciMax Platform for both a multi-national rare disease pharma and a global Med Info Contact Center. Both our clients were looking out for a purpose-built configurable solution that can be tailored and scaled up as their business needs grow. The multi-channel intake, cross-platform integrations, robust case management workflows, built-in reporting & analytics has given them considerable advantage to automate manual tasks and have one single comprehensive solution for all their medical communication needs.

In return, their knowledge capital has been extremely valuable in further strengthening the product’s competence. With two major version releases, today we can claim that SciMax is one of the most advanced cloud solutions in the industry. And we haven’t stopped here because we are already working on the next big wave in infusing artificial intelligence capabilities.

New Capabilities

We are actively working towards announcing the launch of multiple new products and services during this year. Our appetite for innovation has increased with our domain knowledge. Major announcement is the launch of “PVSentinel” cloud solution for pharmacovigilance operations oversight and compliance governance. PVSentinel is a process orchestration and compliance governance solution to streamline, track and report the outcomes of PV operations and cross-functional activities managed by different vendors, partners and affiliates.

We are also working on expanding our service lines to address tech and tech enabled data service capabilities across compliance and quality processes of R&D, Medical and Commercial. We are working towards launching new tech verticals such as Quality, Manufacturing/ Supply, Patient Engagement etc. and new horizontal services such as tech enabled Pharmacovigilance data services.

Work Culture and Team

First and foremost, Techsol’s work culture is fabricated with each team members commitment towards positive outcomes in anything we do. The close-knit collaboration amongst our team members has been visibly recognized by all our clients and that has encouraged our enthusiasm to provide high-quality services all these years.  As part of our corporate responsibility, we have established an amicable work environment with open-door policy, talent recognition, continuous learning support and celebrating our success together.

Our talent pool is constantly nourished with continuous knowledge capital, autonomous work ownership, festival get togethers, social cause shouldering, individual and team empowerment. All these elements positively influence our team to bridge with clients, understand their business goals and work towards common success.

The executive leadership from behind the scenes have been instrumental to ensure that all team members get the best of every client interaction as it an opportunity for them to contribute with their competence and increase the value of the entire business relationship.

We provide growth enabling competitive environment, invest our resources to foster and develop their growth as leaders. Our leadership team that includes engineers, client specialists, sales gurus, scientists, and entrepreneurs, leverage their collective wisdom and capabilities cohesively to create and deliver organization wide focus on client delight. Techsol’ dedicated team works across its two global offices in Princeton (NJ), Hyderabad (India) and Seoul (South Korea) to support our global clientele. Our consistent success in delivering client delight is due to seamless harmony and teamwork between our staff, leadership and board.

Entrepreneur Challenges in the space

The learning curve for mastering tech solutions is pretty steep especially in the pharma industry because of stakeholder variances, cross-functional processes, compliance obligations and the vastness of the tech ecosystem. Today company mergers and acquisitions have increased in multiple folds, therefore there is very little margin to win or lose an opportunity.

For anyone who has dreamed to take the path of Pharma tech entrepreneurship, having the right sense of timing is critical to launch an innovation in a heavily crowded tech market. For new service providers, having the right partnership model is crucial to go against market barriers. Understanding current market trends, innovation landscape, staying updated on regional regulations, observing the pace of technology adoption and gaining competitive intelligence is of paramount importance to win against the odds. The challenge for any new tech innovation in this arena will continue to revolve around quality, compliance and risk. Another key element of is to develop and offer solutions that will continue to scale and grow for your clients over the years.

AI and Next Generation Tech Adoption by Pharma

With the advent of Artificial Intelligence use in many other industries, pharma is preparing its aptitude to gradually adopt it for next generation healthcare. Like any new technology, there is also a great amount of scepticism to believe and accept what AI is perceived to do as to what it really can do.

The fruitful outcomes of AI pilot projects are claiming that it can be a boon for winding down redundant costly processes. Perhaps, it’s true that continuously trained intelligent algorithms can prove their benefit without doubt. But is the industry willing to put AI to work especially for making critical healthcare decisions or for new discovering new paths of disease treatment? Perhaps we will get there soon enough to know it for real.

Key strengths of Techsol:

– Specialized, innovative, software solutions and services company serving Global Pharmaceutical, Life sciences, and Healthcare companies in three verticals – Medical Affairs, Drug Safety and Clinical Development

– Strong presence and leadership position in fast growing Asia Pacific pharma market. Fast growing company in North America market. New entrant in EU and middle east

– Strong promoters and leadership team with committed involvement in company growth over the past 9 years

– Matured, audit ready Quality Management System with relevant certifications, standards, data privacy & protection

– Most preferred strategic partner for Oracle health sciences, world’s largest pharma focused enterprise software company. Very strong techno functional system integration skills on world’s leading drug safety database – Argus Safety

– More than 50 Satisfied and Referenceable pharma customer base across solution areas

– Established, regulatory compliant GxP cloud designed for emerging pharma companies